Prognostic biomarkers in endometrial and ovarian carcinoma
- 7 February 2014
- journal article
- review article
- Published by Springer Nature in Virchows Archiv
- Vol. 464 (3) , 315-331
Abstract
This article reviews the main prognostic and predictive biomarkers of endometrial (EC) and ovarian carcinoma (OC). In EC, prognosis still relies on conventional pathological features such as histological type and grade, as well as myometrial or lymphovascular space invasion. Estrogen receptor, p53, Ki-67, and ploidy analysis are the most promising biomarkers among a long list of molecules that have been proposed. Also, a number of putative predictive biomarkers have been proposed in molecular targeted therapy. In OC, prognosis is predominantly dependent on disease stage at diagnosis and the extent of residual disease at primary operation. Diagnostic markers which aid in establishing histological type in OC are available. However, not a single universally accepted predictive or prognostic marker exists to date. Targeted therapy has been growingly focused at in recent years, in view of the frequent development of chemoresistance at recurrent disease. The present review emphasizes the crucial role of correct pathological classification and stringent selection criteria of the material studied as basis for any evaluation of biological markers. It further emphasizes the promise of targeted therapy in EC and OC, while simultaneously highlighting the difficulties remaining before this can become standard of care.Keywords
This publication has 169 references indexed in Scilit:
- Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patientsBritish Journal of Cancer, 2012
- Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group studyGynecologic Oncology, 2012
- Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeBritish Journal of Cancer, 2012
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysisGynecologic Oncology, 2012
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigmHuman Pathology, 2011
- A seven-gene prognostic model for platinum-treated ovarian carcinomasBritish Journal of Cancer, 2011
- Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy statusTumor Biology, 2011
- Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial CancerThe American Journal of Pathology, 2011
- MicroRNA signatures differentiate uterine cancer tumor subtypesGynecologic Oncology, 2010
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryThe Journal of Pathology, 2010